Ziv-Aflibercept Medication Information

Learn everything you need to know about Ziv-Aflibercept-pronunciation, uses, dosage guidelines, indications, and when to take or avoid it.

Get up-to-date information on side effects, precautions, warnings, and proper storage to ensure safe usage.

Explore Ziv-Aflibercept brand names commonly used in India and internationally, along with detailed pricing information. Consult your healthcare provider for tailored medical advice.

Generic Name : Ziv-Aflibercept

Brand Names or Trade Names of Ziv-Aflibercept

International :

Zaltrap

Why is Ziv-Aflibercept Prescribed? (Indications)

This medication is a recombinant fusion protein, prescribed for metastatic colorectal cancer (mCRC) along with other medications. It blocks certain growth factors that are involved in the formation of new blood vessels in tumors to prevent tumor growth.

When should Ziv-Aflibercept not be taken? (Contraindications)

None.

What is the dosage of Ziv-Aflibercept?

IV- The recommended dose is 4 mg/kg over 1 hour infusion for every two weeks.

How should Ziv-Aflibercept be taken?

It comes as a solution for injection to be administered by a healthcare provider into the vein.

What are the warnings and precautions for Ziv-Aflibercept?

•Discontinue this medication if fistula occurs.

• Monitor blood pressure regularly while taking this medication.

• Patient may develop with increased risk of arterial thromboembolic events, gastrointestinal perforation, and RPLS (also known as posterior reversible encephalopathy syndrome); if it is so consult with your healthcare provider immediately.

What are the side effects of Ziv-Aflibercept?

Infections - Urinary tract infection.
Blood - Decrease in white blood cells and platelets.
Metabolic - Decreased appetite, dehydration.
Central Nervous System - Headache.
Heart - High blood pressure.
Respiratory - Nosebleed, difficulty in breathing, throat pain, runny nose.
Gastrointestinal - Diarrhea, mouth ulcer, abdominal pain, piles, rectal bleeding, and anal cold.
Skin - Palmar-Plantar Erythrodysesthesia Syndrome, hyperpigmentation.
Genitourinary - Protein in urine.
General - Fatigue, weakness and decreased weight.